Beigene Insider Sold Shares Worth $3,756,092, According to a Recent SEC Filing
China's Central Bank Launches Swap Facility to Boost Stock Market
Hong Kong stock market anomaly | Beigene (06160) is currently up more than 8%, officially listed in the USA for tislelizumab, the company's operation losses continue to narrow.
Beigene (06160) is now up more than 8%, as of the time of publication, up 7.32%, trading at 149.6 Hong Kong dollars, with a turnover of 0.393 billion Hong Kong dollars.
Shares of US-listed Chinese Stocks Are Trading Lower After Chinese Planning Officials Reportedly Fell Short of Investor Stimulus Expectations.
China's Stocks Lose Steam as Enthusiasm for Major Stimulus Wanes. What's Next?
BeiGene (BGNE) Moves 5.3% Higher: Will This Strength Last?
